Bryan Harris, Executive Vice President and CTO at SAS
A recent global study by SAS and Coleman Parkes Research reveals that China leads in generative AI (GenAI) usage, with 83% of organizations adopting the technology, compared to 65% in the US.
However, the US excels in full implementation, at 24%, versus China’s 19%. Despite higher adoption in China, effective implementation and returns are better in the US.
“With any new technology, organizations must navigate a discovery phase, separating hype from reality, to understand the complexity of real-world implementations in the enterprise. We have reached this moment with generative AI,” says Bryan Harris, Executive Vice President and CTO at SAS.
“As we exit the hype cycle, it is now about purposefully implementing and delivering repeatable and trusted business results from GenAI.”
The study highlights that organizations face challenges like data privacy, security, and understanding of GenAI, underscoring the need for strategic integration as they navigate this transformative technology.
“While China may lead in GenAI adoption rates, higher adoption doesn’t necessarily equate to effective implementation or better returns,” says Stephen Saw, Managing Director at Coleman Parkes.
“In fact, the US nudges ahead in the race with 24% of organizations having fully implemented GenAI compared to 19% in China.”
Fomca urges government transparency on Budget 2026 cuts, warning healthcare reductions could harm patients, staff,…
PETRONAS and ENEOS renew LNG partnership, securing 10% stake in MLNG Tiga to strengthen energy…
UAE exits OPEC+, weakening spare capacity control and signaling shift toward capacity-driven competition, raising volatility…
Dunlop launches EV-ready tyres under Toyotsu Binter, strengthening Malaysian presence with new products, dealer expansion,…
The FOMC maintained that US economic activity continued to expand at a “solid” pace. Growth…
Finance Ministry raises RON97 and RON95 prices, keeps diesel unchanged, urges prudent fuel use amid…
This website uses cookies.